Dvorah
NDC Package 70362-730-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Dvorah is a . Marketed by Skylar Laboratories, Llc, this product is identified by NDC 70362-730 and is authorized under FDA application ANDA204209.

Identification & Billing

NDC Package Code
70362-730-01
Package Description
100 TABLET in 1 BOTTLE
Product Code
70362-730
11-Digit Billing Format
70362073001

Clinical Specifications

Proprietary Name
Dvorah
Dosage Form
-

Regulatory & Marketing

Labeler Name
Skylar Laboratories, Llc
FDA Application #
ANDA204209
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
12-06-2018
End Marketing Date
03-11-2021
Listing Expiration
03-11-2021
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (70362-730). Click a package code to view its specific billing and regulatory data.

70362-730-30
30 TABLET in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70362-730-01 identifies a specific commercial package of 100 tablet in 1 bottle of Dvorah, labeled by Skylar Laboratories, Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Skylar Laboratories, Llc on December 06, 2018. The current certification is valid through March 11, 2021.

How is this Skylar Laboratories, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70362073001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
70362-730-01
11-Digit CMS (5-4-2)
70362-0730-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.